In June 2020, BSV formed a strategic alliance with LaVoieHealthScience in order to enhance BSV's capabilities to communicate value. <read more here>                     In May 2020, BSV entered into a strategic alliance with FCF Fox Corporate Finance to support funding activities. <read more here>                    
 
                           COVID-19 Portal               Home      About      Team      Clients      Publications      Downloads      News      Career      Contact

Testimonials
  Both, breadth and depth of Bioscience Valuation's economic assessments as well as the company's excellent knowledge of healthcare markets are invaluable assets for me in order to reach my goals.

Rick Jackson, Chairman and CEO
Jackson Healthcare

 

Core Services
  Financial Valuation
  Commercial Assessment &
Pharmacoeconomics

  R&D Risk Analysis &
Productivity Increase

  Portfolio Management
  Investment Decisions
  Partnering / Licensing
  Corporate Finance / M&A

Special Expertise
  Economic Modeling
of Healthcare Systems

  Assessing the Economics
of Personalized Medicine

Comprehensive Support
  Corporate Partnership Program

Products
  Market Model
  R&D Risk Model
  Valuation Model


Contact - Bioscience Valuation

Bioscience Valuation BSV GmbH
Am Zigeunerbergl 3
82491 Grainau
Germany
Phone: +49 8821 966979-0
Fax: +49 8821 966979-29
E-Mail: contact@bioscience-valuation.com


US Representative Office
Dr. Doug Morgan
81 Spring Pond Drive
Ossining, New York 10562
USA
Phone: +1 914-215-0265
E-Mail: d.morgan@bioscience-valuation.com



















This website uses cookies to ensure you get the best experience on our website.
Privacy Policy